Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Kelsey M. Flint"'
Publikováno v:
ESC Heart Failure, Vol 7, Iss 3, Pp 811-824 (2020)
Abstract Aims The aim of this study is to use six previously described heart failure with preserved ejection fraction (HFpEF) phenotypes to describe differences in (i) the biological response to spironolactone, (ii) clinical endpoints, and (iii) pati
Externí odkaz:
https://doaj.org/article/6d3cc44c9edd428c8a26f7571a5fb776
Autor:
Lubin R. Deng, Vincenzo B. Polsinelli, Vinay Kini, Morgan Wilson, Pamela Peterson, David B. Bekelman, Kelsey M. Flint
BackgroundDespite CMS coverage expansion supporting cardiac rehabilitation (CR) in patients with heart failure (HF) in 2014, data suggest that utilization among patients with HF is low. We describe CR participation and adherence among HF patients in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::345eba8b6564e1ae9fa9fe9d3ada9f77
https://doi.org/10.1101/2023.03.01.23286662
https://doi.org/10.1101/2023.03.01.23286662
Autor:
Jocelyn S. Thompson, Erin L. Chaussee, Kamal Henderson, Kelsey M. Flint, Shane J. LaRue, Colleen K. McIlvennan, Prateeti Khazanie, Larry A. Allen, Khadijah Breathett, Daniel D. Matlock
Publikováno v:
J Card Fail
Background A left ventricular assist device (LVAD) is a treatment option available to select patients with advanced heart failure. However, there are important social determinants of health that can play a role in determining patients’ outcomes aft
Autor:
Rosa Cardenal-Piris, Felipe Fernández-Vázquez, Creighton W. Don, Francesca Valentini, Simon Parlow, Nicolina Conti, Mohamad A. Alkhouli, Alessandra Berardini, Dan Haberman, Amos Levi, Claudio Rapezzi, Marino Labinaz, Marta Bargagna, Luca Branca, Thierry G. Mesana, Benjamin Hibbert, Elena Biagini, Tomás Benito-González, Nicola Buzzatti, Risa Shorr, Richard G. Jung, Davide Schiavi, Sinisa Markovic, Marianna Adamo, José Francisco Díaz Fernández, Federico Pappalardo, Pietro Di Santo, Trevor Simard, Alessandra Sala, Christopher P. Kovach, Vincent Chan, Mony Shuvy, Claudia Marini, Paolo Denti, Mark Hynes, Rodrigo Estévez-Loureiro, Kelsey M. Flint, Ana J. Manovel, Maurizio Taramasso
Publikováno v:
JACC: Cardiovascular Interventions. 14:1-11
Objectives: The aim of this study was to evaluate the outcome of transcatheter mitral valve repair (TMVr) in patients with cardiogenic shock and significant mitral regurgitation (MR). Background: Patients in cardiogenic shock with severe MR have a po
Publikováno v:
Circulation: Heart Failure. 15
Publikováno v:
ESC Heart Failure
ESC Heart Failure, Vol 7, Iss 3, Pp 811-824 (2020)
ESC Heart Failure, Vol 7, Iss 3, Pp 811-824 (2020)
Aims The aim of this study is to use six previously described heart failure with preserved ejection fraction (HFpEF) phenotypes to describe differences in (i) the biological response to spironolactone, (ii) clinical endpoints, and (iii) patient‐rep
Publikováno v:
Journal of Cardiopulmonary Rehabilitation and Prevention. 40:72-78
Older adults with cardiovascular disease (CVD) pose challenges to cardiac rehabilitation (CR) clinicians because their disease is often coupled to physical frailty. Older patients with CVD and frailty may be less likely to tolerate conventional CR ex
Autor:
Kelsey M. Flint
Publikováno v:
Circulation: Heart Failure. 14
Publikováno v:
Clinics in Geriatric Medicine. 35:517-526
Cardiac rehabilitation (CR) is a structured exercise and lifestyle program that improves mortality and quality of life in patients with heart failure (HF) with reduced ejection fraction. However, significant gaps remain in optimizing CR for older adu
Publikováno v:
European Heart Journal - Quality of Care and Clinical Outcomes. 5:233-241
Aims Patients with heart failure often have under-recognized symptoms, depression, anxiety, and poorer spiritual well-being (‘QoL domains’). Ideally all patients should have heart failure-specific health status and quality of life (QoL) domains r